REGENERX BIOPHARMACEUTICALS INC Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Regenerx Biopharmaceuticals Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q1 2023.
  • Regenerx Biopharmaceuticals Inc Common Stock, Shares, Outstanding for the quarter ending March 31, 2023 was 144M shares, unchanged year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 144M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 144M 0 0% Dec 31, 2022 10-Q 2023-05-15
Q3 2022 144M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 144M +103K +0.07% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 144M +10M +7.49% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 144M +10.1M +7.58% Dec 31, 2021 10-K 2023-04-11
Q3 2021 144M +10.1M +7.58% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 143M +10M +7.5% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 134M +105K +0.08% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 133M +1.94M +1.47% Dec 31, 2020 10-K 2022-03-30
Q3 2020 133M +1.94M +1.47% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 133M +1.94M +1.47% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 133M +2.94M +2.25% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 132M +3.07M +2.39% Dec 31, 2019 10-K 2021-03-02
Q3 2019 132M +3.07M +2.39% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 132M +11.9M +9.92% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 131M +10.9M +9.09% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 128M +18.6M +17% Dec 31, 2018 10-K 2020-03-20
Q3 2018 128M +21.5M +20.2% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 120M +12.8M +11.9% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 120M +12.9M +12% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 110M +3M +2.81% Dec 31, 2017 10-K 2019-03-29
Q3 2017 107M +95.6K +0.09% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 107M +95.6K +0.09% Jun 30, 2017 10-Q 2017-08-21
Q1 2017 107M +5.15M +5.06% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 107M +5.15M +5.06% Dec 31, 2016 10-K 2018-03-29
Q3 2016 107M +5.15M +5.06% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 107M +5.15M +5.06% Jun 30, 2016 10-Q 2016-08-22
Q1 2016 102M +324K +0.32% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 102M +324K +0.32% Dec 31, 2015 10-K 2017-03-29
Q3 2015 102M +324K +0.32% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 102M +8.66M +9.31% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 101M +8.33M +8.96% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 101M +19.6M +24% Dec 31, 2014 10-K 2016-04-11
Q3 2014 101M +19.6M +24% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 93M +11.3M +13.8% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 93M +11.3M +13.8% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 81.7M 0 0% Dec 31, 2013 10-K 2015-03-31
Q3 2013 81.7M 0 0% Sep 30, 2013 10-Q 2013-11-18
Q2 2013 81.7M +54.2K +0.07% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 81.7M +343K +0.42% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 81.7M +343K +0.42% Dec 31, 2012 10-K 2014-04-04
Q3 2012 81.7M +1.16M +1.44% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 81.7M +1.72M +2.15% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 81.4M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 81.4M +7.86M +10.7% Dec 31, 2011 10-K 2013-04-16
Q3 2011 80.6M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 80M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 73.5M Dec 31, 2010 10-K 2012-04-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.